Anthropic confirms operation of physical biology laboratory in Bay Area

Anthropic has confirmed to TechCrunch that it operates a wet biology laboratory in the Bay Area, where the company uses its artificial intelligence models to conduct physical experiments. This development marks a significant step for the AI firm, which has previously focused on software development, as it moves to integrate its models with tangible scientific research. The existence of the lab was not widely known until now, although industry insiders had speculated about Anthropic’s expanding capabilities in the life sciences sector.

The company stated that the laboratory functions similarly to traditional biotech facilities, where Anthropic conducts internal research while also collaborating with external partners. Eric Kauderer-Abrams, the head of life sciences at Anthropic, explained to Reuters that the final test for biological applications remains physical lab work. He emphasised that the team is actively engaged in this process today, reinforcing the company’s commitment to validating its AI-driven theories through real-world experimentation. This approach aligns with broader industry assertions that artificial intelligence will play a crucial role in curing human disease within the next five to ten years.

Anthropic declined to provide specific details regarding the current projects underway in the lab. However, the company clarified that the primary focus is on fundamental biology rather than drug discovery. This distinction is likely intended to avoid the perception that Anthropic is competing directly with the pharmaceutical industry, where it maintains numerous major customers and partners. The company recently announced a deal to work with Novo Nordisk on joint drug discovery, highlighting its existing relationships in the sector. Anthropic has previously faced criticism for launching products that were perceived to compete with those of its clients, a dynamic it appears keen to manage carefully.

In a related move, Anthropic launched a Life Sciences Verification Program this week. This initiative provides vetted bio researchers with access to the company’s most powerful models. Additionally, the firm has published recent reports detailing its research efforts to support drug discovery, including studies on accelerating protein design and improving bimolecular modelling. These publications aim to demonstrate the practical applications of its technology in scientific research.

The announcement of the wet lab comes amid heightened debate regarding the safety and risks of advanced AI. The resignation of Anthropic researcher Jacob Coxon recently drew attention, as he warned that some in the field believe AI could pose an existential threat to humanity by the end of the decade. Anthropic’s own alignment lead has estimated the probability of AI causing human extinction within the next ten years to be greater than ten percent. In response to these concerns, CEO Dario Amodei has called for the industry to slow down and implement self-regulation, citing bioterrorism as one of the major risks associated with AI development. The juxtaposition of these dire warnings with the company’s expansion into physical biology has not gone unnoticed in the tech industry, with some commentators noting the irony of a group advocating for caution while building new experimental capabilities.